Not registered yet? Please contact our project manager Dr. Sara Stöber . This area is only for members of the research consortium.


6-8 December 2023

5th General Assembly & Patient Event

Preparations for the 5th General Assembly (GA) Meeting in Leiden, NL, from 6-8 December 2023 are going strong. We’re kicking things off with the QSPainRelief Patient Event & Podium Discussion on Wednesday, December 6th (14:00-16:00h), hosted by the Centre for Human Drug Research (CHDR). The event will be in Dutch. More details will follow soon!

More news


6 December 2023

Patient Event & Panel Discussion

We cordially invite chronic pain patients, relatives, and interested laymen to our 2nd QSPainRelief Patient Event at the Centre for Human Drug Research (CHDR) in Leiden on Wednesday, 6th December 2023. The event will be in Dutch language at CHDR’s auditorium from 14:00-16:00h. The panel discussion will focus on how to improve patient involvement in clinical studies. Online attendance is also an option, see agenda for details. We look forward to hosting you – please register here!

More events
Personalise and maximize pain relief for individuals suffering from chronic pain

Summary Statement

10 institutions in Europe and the USA collaborate for the next 5 years to help patients suffering from chronic pain. QSPainRelief aims to develop effective drug combination treatments for the improved relief of chronic pain. A quantitative systems pharmacology (QSP) mathematical modelling approach will be used to identify and validate more effective therapeutic interventions by smart combinations of existing drugs. The ultimate goal is to personalise and maximize pain relief for individuals suffering from chronic pain while diminishing side effects.

Learn more


  • Consolidating cutting-edge treatment models for chronic pain
  • Summary Statement
  • Validating novel combinational therapies preclinically in vitro and in vivo
  • Conducting clinical studies to detect functional biomarkers
  • Improving the clinical guidelines for pain relief in stratified patient groups
  • Personalising pain relief treatment for each patient
  • Improving the scientific understanding of chronic pain regarding age, sex, disease and genetic factors


  • Novel concepts of combinational pain relief therapies
  • Improved efficacy and acceptability in the clinic
  • Effective stratification of patients with respect to age, sex, disease and genotype
  • Personalised treatment with unswerving benefits for patients
  • Unique knowledge gain and innovation opportunities